106 related articles for article (PubMed ID: 25227983)
41. Elevated levels of circulating CD44 in patients with systemic sclerosis: association with a milder subset.
Komura K; Sato S; Fujimoto M; Hasegawa M; Takehara K
Rheumatology (Oxford); 2002 Oct; 41(10):1149-54. PubMed ID: 12364635
[TBL] [Abstract][Full Text] [Related]
42. Molecular quantification of response to therapy and remission status in TEL-AML1-positive childhood ALL by real-time reverse transcription polymerase chain reaction.
Seeger K; Kreuzer KA; Lass U; Taube T; Buchwald D; Eckert C; Körner G; Schmidt CA; Henze G
Cancer Res; 2001 Mar; 61(6):2517-22. PubMed ID: 11289124
[TBL] [Abstract][Full Text] [Related]
43. Evaluation of some biochemical markers as prognostic factors in malignant lymphoma.
Khalifa KA; Alkilani AA; Ismail H; Soliman MA
J Egypt Natl Canc Inst; 2008 Mar; 20(1):47-54. PubMed ID: 19847281
[TBL] [Abstract][Full Text] [Related]
44. Childhood leukemia genetic bottleneck phenomenon related to TEL-AML1: the postulation by a mathematical model.
Ivanovski P; Ivanovski I; Nikolić D; Jovanović I
Chin Med J (Engl); 2012 Mar; 125(6):1182-5. PubMed ID: 22613552
[TBL] [Abstract][Full Text] [Related]
45. Expression of Tel-Aml1 transcript variants in pediatric acute lymphoblastic leukemia.
Kustanovich AM; Belevtsev MV; Stasevich IV; Savitskaya TV; Jutzkevich RI; Savva NN; Aleinikova OV
Leukemia; 2006 Jan; 20(1):165-7. PubMed ID: 16307024
[No Abstract] [Full Text] [Related]
46. [Immunophenotypic characteristics of children with acute lymphoblastic leukemia carrying TEL-AML1 fusion gene].
Liu Y; Li ZG; Zhao W; Li B; Gong WY; Wu MY
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2006 Aug; 14(4):714-6. PubMed ID: 16928306
[TBL] [Abstract][Full Text] [Related]
47. Favorable outcome in 20-year follow-up of children with very-low-risk ALL and minimal standard therapy, with special reference to TEL-AML1 fusion.
Kanerva J; Saarinen-Pihkala UM; Niini T; Riikonen P; Möttönen M; Mäkipernaa A; Salmi TT; Vettenranta K; Knuutila S
Pediatr Blood Cancer; 2004 Jan; 42(1):30-5. PubMed ID: 14752791
[TBL] [Abstract][Full Text] [Related]
48. Predictive relevance of soluble CD44v6 serum levels for the responsiveness to second line hormone- or chemotherapy in patients with metastatic breast cancer.
Kopp R; Classen S; Wolf H; Gholam P; Possinger K; Wilmanns W
Anticancer Res; 2001; 21(4B):2995-3000. PubMed ID: 11712800
[TBL] [Abstract][Full Text] [Related]
49. TEL/AML1 fusion gene in childhood acute lymphoblastic leukemia in southern Taiwan.
Lin PC; Chang TT; Lin SR; Chiou SS; Jang RC; Sheen JM
Kaohsiung J Med Sci; 2008 Jun; 24(6):289-96. PubMed ID: 18635414
[TBL] [Abstract][Full Text] [Related]
50. Effect of the histone deacetylase inhibitor depsipeptide on B-cell differentiation in both TEL-AML1-positive and negative childhood acute lymphoblastic leukemia.
Stams WA; den Boer ML; Beverloo HB; Kazemier KM; van Wering ER; Janka-Schaub GE; Pieters R
Haematologica; 2005 Dec; 90(12):1697-9. PubMed ID: 16330447
[TBL] [Abstract][Full Text] [Related]
51. TEL-AML1 transgenic zebrafish model of precursor B cell acute lymphoblastic leukemia.
Sabaawy HE; Azuma M; Embree LJ; Tsai HJ; Starost MF; Hickstein DD
Proc Natl Acad Sci U S A; 2006 Oct; 103(41):15166-71. PubMed ID: 17015828
[TBL] [Abstract][Full Text] [Related]
52. High expression of cytoskeletal protein drebrin in TEL/AML1pos B-cell precursor acute lymphoblastic leukemia identified by a novel monoclonal antibody.
Vaskova M; Kovac M; Volna P; Angelisova P; Mejstrikova E; Zuna J; Brdicka T; Hrusak O
Leuk Res; 2011 Aug; 35(8):1111-3. PubMed ID: 21497902
[TBL] [Abstract][Full Text] [Related]
53. Levels of the soluble, 55-kilodalton isoform of tumor necrosis factor receptor in bone marrow are correlated with the clinical outcome of children with acute lymphoblastic leukemia in first recurrence.
Wu S; Korte A; Gessner R; Henze G; Seeger K
Cancer; 2003 Aug; 98(3):625-31. PubMed ID: 12879482
[TBL] [Abstract][Full Text] [Related]
54. Immunogenotype changes prevail in relapses of young children with TEL-AML1-positive acute lymphoblastic leukemia and derive mainly from clonal selection.
Panzer-Grümayer ER; Cazzaniga G; van der Velden VH; del Giudice L; Peham M; Mann G; Eckert C; Schrauder A; Germano G; Harbott J; Basso G; Biondi A; van Dongen JJ; Gadner H; Haas OA
Clin Cancer Res; 2005 Nov; 11(21):7720-7. PubMed ID: 16278392
[TBL] [Abstract][Full Text] [Related]
55. The use of pleural fluid sCD44v6/std ratio for distinguishing mesothelioma from other pleural malignancies.
Porcel JM; Esquerda A; Rodriguez-Panadero F; Martínez-Iribarren A; Bielsa S
J Thorac Oncol; 2011 Jan; 6(1):190-4. PubMed ID: 21079519
[TBL] [Abstract][Full Text] [Related]
56. Significant elevation of tumour-associated isoforms of soluble CD44 in serum of normal individuals caused by cigarette smoking.
Kittl EM; Ruckser R; Rech-Weichselbraun I; Hinterberger W; Bauer K
Eur J Clin Chem Clin Biochem; 1997 Feb; 35(2):81-4. PubMed ID: 9056747
[TBL] [Abstract][Full Text] [Related]
57. High incidence of TEL/AML1 fusion resulting from a cryptic t(12;21) in childhood B-lineage acute lymphoblastic leukemia in Taiwan.
Liang DC; Chou TB; Chen JS; Shurtleff SA; Rubnitz JE; Downing JR; Pui CH; Shih LY
Leukemia; 1996 Jun; 10(6):991-3. PubMed ID: 8667657
[TBL] [Abstract][Full Text] [Related]
58. Rapid quantitative detection of TEL-AML1 fusion transcripts in pediatric acute lymphoblastic leukemia by real-time reverse transcription polymerase chain reaction using fluorescently labeled probes.
Bolufer P; Barragán E; Verdeguer A; Cervera J; Fernández JM; Moreno I; Lerma E; Esquembre C; Tasso M; Fuster V; Bermúdez M; Sanz MA
Haematologica; 2002 Jan; 87(1):23-32. PubMed ID: 11801462
[TBL] [Abstract][Full Text] [Related]
59. Histone deacetylase inhibition improves differentiation of dendritic cells from leukemic blasts of patients with TEL/AML1-positive acute lymphoblastic leukemia.
Schmidt K; Seeger K; Scheibenbogen C; Bender R; Abdulla M; Süssmilch S; Salama A; Moldenhauer A
J Leukoc Biol; 2009 Mar; 85(3):563-73. PubMed ID: 19129484
[TBL] [Abstract][Full Text] [Related]
60. Role of VEGF and CD44v6 in differentiating benign from malignant ascites.
Dong WG; Sun XM; Yu BP; Luo HS; Yu JP
World J Gastroenterol; 2003 Nov; 9(11):2596-600. PubMed ID: 14606105
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
